http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021161099-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_195ca53b2ef9a3f29c6a53eabdf51283
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02B20-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K63-06
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H05B47-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H05B47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H05B45-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H05B45-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K15-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H05B47-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H05B45-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H05B44-00
filingDate 2019-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3563871f687d37d753a1b665bb86ea4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6f676983e4a8bfd38f9c77705de113f
publicationDate 2021-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021161099-A1
titleOfInvention Beneficial applications of uva1 light
abstract A light engine that produces UVA 1 light, but not UVA 2 or UVB radiation, that will provide a human or animal subject a beneficial application of artificial UVA 1 light without the deleterious effect of the UVA 2 and UVB light. Methods of providing UVA 1 light to the human or animal subject over various periods of time provide positive treatments that can reduce stress, reduce anxiety, increase a pain threshold, and induce interferon production. Exposure to UVA 1 wavelength light (360-400 nm) provides a positive effect on both humans and animals. This is especially true when the humans or animals do not receive UVB and UVA 2 at the time that the UVA 1 light is received, and the ratio of UVA 1 light to (UVA 1 light+visible light) is greater than 10%.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020267949-A1
priorityDate 2018-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID736715

Total number of triples: 29.